302 related articles for article (PubMed ID: 29080212)
21. Spotlight on small molecules in cardiovascular diseases.
Wang X; Huang Y; Ji Y
Br J Pharmacol; 2018 Apr; 175(8):1111-1113. PubMed ID: 29574891
[TBL] [Abstract][Full Text] [Related]
22. Nicotinic acetylcholine receptors.
Wonnacott S; Bermudez I; Millar NS; Tzartos SJ
Br J Pharmacol; 2018 Jun; 175(11):1785-1788. PubMed ID: 29878346
[TBL] [Abstract][Full Text] [Related]
23. Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.
Foks AC; Kuiper J
Br J Pharmacol; 2017 Nov; 174(22):3940-3955. PubMed ID: 28369782
[TBL] [Abstract][Full Text] [Related]
24. Highlights into the pharmacology of nutraceuticals.
Andrew R; Izzo AA
Br J Pharmacol; 2020 Mar; 177(6):1209-1211. PubMed ID: 32133625
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms regulating perivascular adipose tissue - potential pharmacological targets?
Kennedy S; Salt IP
Br J Pharmacol; 2017 Oct; 174(20):3385-3387. PubMed ID: 28940457
[TBL] [Abstract][Full Text] [Related]
26. Molecular pharmacology of GPCRs.
Langmead CJ; Summers RJ
Br J Pharmacol; 2018 Nov; 175(21):4005-4008. PubMed ID: 30302756
[TBL] [Abstract][Full Text] [Related]
27. The importance of sex differences in pharmacology research.
Gogos A; Langmead C; Sullivan JC; Lawrence AJ
Br J Pharmacol; 2019 Nov; 176(21):4087-4089. PubMed ID: 31769019
[TBL] [Abstract][Full Text] [Related]
28. New insights into cardiotoxicity caused by chemotherapeutic agents.
Grieve DJ; Davidson SM
Br J Pharmacol; 2017 Nov; 174(21):3675-3676. PubMed ID: 29046013
[TBL] [Abstract][Full Text] [Related]
29. Drug metabolism and antibiotic resistance in micro-organisms.
Sim E; Ryan A
Br J Pharmacol; 2017 Jul; 174(14):2159-2160. PubMed ID: 28463394
[TBL] [Abstract][Full Text] [Related]
30. When pharmacology meets the microbiome: new targets for therapeutics?
Hyland NP; Cryan JF
Br J Pharmacol; 2018 Dec; 175(24):4401-4403. PubMed ID: 30478976
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial pharmacology: featured mechanisms and approaches for therapy translation.
Wang X; Galli G; Campanella M
Br J Pharmacol; 2019 Nov; 176(22):4245-4246. PubMed ID: 31793696
[TBL] [Abstract][Full Text] [Related]
32. Proteinase activated receptor-2 counterbalances the vascular effects of endothelin-1 in fibrotic tight-skin mice.
Roviezzo F; Brancaleone V; Mattera Iacono V; Bertolino A; De Cunto G; Vellecco V; Lungarella G; Lucattelli M; Cirino G
Br J Pharmacol; 2017 Nov; 174(22):4032-4042. PubMed ID: 27625162
[TBL] [Abstract][Full Text] [Related]
33. Recent progress in the understanding of relaxin family peptides and their receptors.
Summers RJ
Br J Pharmacol; 2017 May; 174(10):915-920. PubMed ID: 28447360
[TBL] [Abstract][Full Text] [Related]
34. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.
Petrosino S; Di Marzo V
Br J Pharmacol; 2017 Jun; 174(11):1349-1365. PubMed ID: 27539936
[TBL] [Abstract][Full Text] [Related]
35. Tipping the scales: Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction?
Taylor LE; Ramirez LA; Musall JB; Sullivan JC
Br J Pharmacol; 2019 Nov; 176(21):4226-4242. PubMed ID: 31271650
[TBL] [Abstract][Full Text] [Related]
36. The role of the mineralocorticoid receptor in immune cells in cardiovascular disease.
van der Heijden CDCC; Bode M; Riksen NP; Wenzel UO
Br J Pharmacol; 2022 Jul; 179(13):3135-3151. PubMed ID: 34935128
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoids and their actions: An update.
Alexander SPH; Molina-Holgado F
Br J Pharmacol; 2019 May; 176(10):1359-1360. PubMed ID: 31032895
[TBL] [Abstract][Full Text] [Related]
38. Opioid research in the time of the opioid crisis.
Traynor JR; Moron JA
Br J Pharmacol; 2023 Apr; 180(7):793-796. PubMed ID: 36813266
[TBL] [Abstract][Full Text] [Related]
39. Bioactive polyphenols and cardiovascular disease: chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response?
Goszcz K; Duthie GG; Stewart D; Leslie SJ; Megson IL
Br J Pharmacol; 2017 Jun; 174(11):1209-1225. PubMed ID: 28071785
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological basis and new insights of resveratrol action in the cardiovascular system.
Cheng CK; Luo JY; Lau CW; Chen ZY; Tian XY; Huang Y
Br J Pharmacol; 2020 Mar; 177(6):1258-1277. PubMed ID: 31347157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
